Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings

Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings

Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Never...

Full description

Bibliographic Details
Main Authors: Elnaem, Mohamed Hassan, Nik Mohamed, Mohamad Haniki
Format: Article
Language:English
Published: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2017
Subjects:
RM Therapeutics. Pharmacology
RM283 Endocrinotheraphy
Online Access:http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf
id iium-58961
recordtype eprints
spelling iium-589612017-11-01T07:43:16Z http://irep.iium.edu.my/58961/ Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings Elnaem, Mohamed Hassan Nik Mohamed, Mohamad Haniki RM Therapeutics. Pharmacology RM283 Endocrinotheraphy Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Nevertheless, the suboptimal management of diabetic dyslipidemia in the Malaysian primary care settings has been reported. This study aimed to describe the statin therapy prescribing pattern among patients with T2DM, evaluate the appropriateness of statin therapy prescribing, and assess the level of achievement of the primary target (LDL-C) for diabetic dyslipidemia treatment. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2017-10-19 Article PeerReviewed application/pdf en http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf Elnaem, Mohamed Hassan and Nik Mohamed, Mohamad Haniki (2017) Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings. Value in Health, 20 (9). A486. ISSN 1098-3015 http://www.valueinhealthjournal.com/article/S1098-3015(17)30831-8/pdf 10.1016/j.jval.2017.08.497
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RM Therapeutics. Pharmacology
RM283 Endocrinotheraphy
spellingShingle RM Therapeutics. Pharmacology
RM283 Endocrinotheraphy
Elnaem, Mohamed Hassan
Nik Mohamed, Mohamad Haniki
Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
description Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Nevertheless, the suboptimal management of diabetic dyslipidemia in the Malaysian primary care settings has been reported. This study aimed to describe the statin therapy prescribing pattern among patients with T2DM, evaluate the appropriateness of statin therapy prescribing, and assess the level of achievement of the primary target (LDL-C) for diabetic dyslipidemia treatment.
format Article
author Elnaem, Mohamed Hassan
Nik Mohamed, Mohamad Haniki
author_facet Elnaem, Mohamed Hassan
Nik Mohamed, Mohamad Haniki
author_sort Elnaem, Mohamed Hassan
title Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
title_short Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
title_full Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
title_fullStr Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
title_full_unstemmed Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
title_sort assessment of lipid-lowering therapy prescribing among patients with type 2 diabetes mellitus in malaysian primary care settings
publisher International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
publishDate 2017
url http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf
first_indexed 2023-09-18T21:23:26Z
last_indexed 2023-09-18T21:23:26Z
_version_ 1777412034518843392

Similar Items